| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8217618 | International Journal of Radiation Oncology*Biology*Physics | 2015 | 7 Pages |
Abstract
A persisting PSA after prostatectomy seems to be an important prognosticator of clinical progression for pT3 tumors. It correlates with a higher rate of distant metastases and with worse overall survival. A larger prospective study is required to determine which patient subgroups will benefit most from which treatment option.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Thomas MD, Detlef PhD, Dirk MD, Reinhard MD, Axel PhD, Michael MD, Christian MD, Axel MD, Manfred MD, Stephan MD, Reinhard MD, Rita MD, Rainer MD, Horst-Jürgen MD, Tilman MD, Alessandra MD, Wolfgang MD, Ursula MD, Kurt MD,